Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial-Reference-Cited by-同舟云学术

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial

Published:2023-11 Issue: Volume:40 Page:100898
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Chiang Chi Leung^ORCID,Lam Tai Chung,Li James Chun Bong,Chan Kenneth Sik Kwan,El Helali Aya^ORCID,Lee Yolanda Yim Ping,Law Laalaa Hiu Ting,Zheng Danyang,Lo Anthony Wing Ip^ORCID,Kam Ngar Woon,Li Wing Sum,Cheung Alice Ka Wai,Chow James Chung Hang,Chan Sunny Po Chung,Lai Jessica Wing Yu,Lee Sarah Wai Man,Kong Feng-Ming (Spring),Ng Wai Tong,Kwong Dora Lai Wan,Lee Anne Wing Mui

Funder

Merck KGaA

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference61 articles.

1. Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: focus on low-risk areas;Carioli;Int J Cancer,2017

2. Nasopharyngeal carcinoma;Chua;Lancet,2016

3. Management of nasopharyngeal carcinoma: current practice and future perspective;Lee;J Clin Oncol,2015

4. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial;Zhang;Lancet,2016

5. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma;Ma;Cancer,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: a systematic review and meta-analysis of prospective trials;Frontiers in Oncology;2024-06-03

2. Unfolding the Complexity of Exosome–Cellular Interactions on Tumour Immunity and Their Clinical Prospects in Nasopharyngeal Carcinoma;Cancers;2024-02-24

3. PD-1 inhibitors combined with chemotherapy versus chemotherapy alone: efficacy and prognostic analysis in recurrent metastatic nasopharyngeal carcinoma;American Journal of Translational Research;2024